Lisa Wang is a psychiatrist currently working at a private practice and serving as a trainer for Fluence since April 2022. In addition to these roles, Lisa is a sub-investigator for the Multidisciplinary Association for Psychedelic Studies (MAPS), overseeing the MDMA-Assisted Psychotherapy for PTSD Study, and works as a clinician at the New York State Psychiatric Institute, focusing on psychedelic-assisted therapies for treatment-resistant depression and body dysmorphic disorder. Previously, Lisa completed a psychiatry residency at Columbia University and the New York State Psychiatric Institute from July 2017 to June 2021 and has academic training that includes an M.D. from NYU School of Medicine and a BA in Religious Studies from Northwestern University.
This person is not in any offices
Multidisciplinary Association for Psychedelic Studies (MAPS)
Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. We further our mission by: ● Developing psychedelics and marijuana into prescription medicines ● Training therapists and working to establish a network of treatment centers ● Supporting scientific research into spirituality, creativity, and neuroscience ● Educating the public honestly about the risks and benefits of psychedelics and marijuana